Transaction Data Systems Announces Closing of Merger with Outcomes™
Summary
“Both TDS and Outcomes have been centered on enhancing the pharmacy’s delivery of clinical care and enabling diversified revenue streams,” said Weitzman. “This is an exciting day for pharmacists looking to operate at the top of their license as trusted community healthcare providers.” “Our mission is grounded in the power of pharmacy to improve patient care outcomes,” said Stutz, “Today’s closing will position Outcomes for further growth to continue to deliver on the patient experience by expanding our pharmacy footprint and providing richer opportunities to scale our payer and pharma connections.” Simpson Thacher & Bartlett LLP served as legal adviser to TDS, while SVB Securities acted as financial adviser. BlackRock LTPC is an innovative private equity strategy focused on investing in high-quality businesses and value creation through active collaboration with management teams. The strategys flexible duration and prudent approach to leverage preserve optionality for growth and help enable compounded capital appreciation. LTPC is backed by BlackRock, Inc., which manages $320 billion in alternative investments and commitments on behalf of clients worldwide as of March 31, 2023.